
Market view
Stock chart
Coverage
Analyses on Foresight (3)
- March 25, 2026March 25, 2026
- Follow-up
Foresight: How Much of the Pipeline Is Real Commercialization
Foresight’s 20-F presents a wide commercialization pipeline, but as of 2025 only Elbit clearly crossed into identifiable revenue, while most of the other key threads still sit in POCs, development work, or commercial discussions.

- Follow-up
Foresight: Eye-Net Funding Changed the Value Split
Eye-Net’s two 2025 funding rounds extended Foresight’s runway, but they also changed the value split in a material way: Foresight fell to 89.36% ownership in Eye-Net, granted anti-dilution protection at the subsidiary, and built a large warrant layer at the listed parent.

Foresight in 2025: Commercialization Still Does Not Justify the Dilution
Foresight expanded its technology proof layer and extended its financing runway in 2025, but revenue remains far too small relative to the cost base, so commercialization still does not justify the dilution.

Same sector






























